Age
Item
Adult patient (≥ 18 years)
boolean
C0001779 (UMLS CUI [1])
Hospitalization
Item
Patient hospitalized
boolean
C0019993 (UMLS CUI [1])
Systemic antibiotic treatment
Item
Patient receives systemic antibiotic treatment
boolean
C3540704 (UMLS CUI [1])
Legal competency
Item
Patient contractually capable
boolean
C0680554 (UMLS CUI [1])
Compliance
Item
Patient able to follow study procedures
boolean
C1321605 (UMLS CUI [1])
Informed consent
Item
Informed consent of patient
boolean
C0021430 (UMLS CUI [1])
Control Group
Item
Healthy Volunteers
boolean
C0009932 (UMLS CUI [1])
Hypersensitivity
Item
allergy against yeast and/or Perenterol® forte und/oder placebos containing Saccharomyces cerevisiae HANSEN CBS 5926, lactose-monohydrate, magnesium stearate, gelatine, sodium dodecyl sulfate, titan dioxide, microcrystalline cellulose.
boolean
C0020517 (UMLS CUI [1])
Central venous catheter
Item
Central venous catheter
boolean
C1145640 (UMLS CUI [1])
Immunosuppression
Item
Immunosuppression
boolean
C0021079 (UMLS CUI [1])
Diarrhea
Item
Diarrhoea and/or chronic diarrhoea
boolean
C0011991 (UMLS CUI [1])
Pharmacotherapy
Item
Regular intake of Perenterol®, Perenterol® forte oder Yomogi® in the last seven days before the start of the study
boolean
C0013216 (UMLS CUI [1])
Systemic antimycotic treatment
Item
Systemic antimycotic treatment
boolean
C3653762 (UMLS CUI [1])
Prior Antibiotic Treatment
Item
Systemic antibiotic treatment within the last 6 weeks
boolean
C0003232 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
Gynaecological Status
Item
No protection against conception, pregnancy, or lactation
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
Study Participation Status
Item
Simultaneous participation in other clinical trials
boolean
C2348568 (UMLS CUI [1])